𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose Medroxyprogesterone Acetate versus Estramustine in Therapy-resistant Prostatic Cancer: A Randomised Study

✍ Scribed by J.-E. JOHANSSON; S.-O. ANDERSSON; L. HOLMBERG

Book ID
115196452
Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
494 KB
Volume
68
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of high-dose medroxypro
A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer
✍ Geoffrey Falkson; HΓ¨ndrΓ© C. Falkson πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 215 KB

Twenty-three evaluable patients with advanced breast cancer were treated with MPA, 1,400 mg/m2 daily PO for the first 6 months, and 500 mg/m2 daily PO thereafter. The median total dose was 191,400 mg in 88 days, with the maximum dose given to date 522,600 mg in 282 days. Most patients tolerated high